MENINGITIS B VACCINE
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 16, 2017
app pub date -
Nov 27, 2015
filing date -
Nov 28, 2014
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Compositions, including vaccine compositions, are provided comprising outer membrane vesicles (OMVs) from N. meningitidis B (MenB). Also provided are methods of making such compositions comprising growing MenB in culture and isolating the OMVs produced, and the use of MenB vaccine compositions for prevention of meningitis in a subject.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully